Analyst IMS Investment Management Services’s AbbVie ABBV Stock Holding History

Analyst IMS Investment Management Services’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.12M	Buy	5,145 +364	+8%	+$80.7K	0.03%	81
2025 Q4	$1.09M	Buy	4,781 +2,020	+73%	+$460K	0.03%	78
2025 Q3	$639K	Sell	2,761 -424	-13%	-$86.3K	0.02%	102
2025 Q2	$591K	Sell	3,185 -2,409	-43%	-$448K	0.02%	106
2025 Q1	$1.17M	Buy	5,594 +2,286	+69%	+$444K	0.05%	78
2024 Q4	$588K	Sell	3,308 -1,697	-34%	-$312K	0.02%	101
2024 Q3	$988K	Buy	5,005 +2,018	+68%	+$377K	0.04%	79
2024 Q2	$512K	Buy	+2,987	New	+$495K	0.02%	99

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Analyst IMS Investment Management Services's ABBV Position: Q1 2026 in Review

Analyst IMS Investment Management Services increased its AbbVie (ABBV) stake by 7.6% in Q1 2026, buying an estimated $80.7K and bringing the position to 5,145 shares worth $1.12M. The position accounts for 0.03% of the portfolio, ranked #81.

Analyst IMS Investment Management Services first reported a position in ABBV in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.17M in Q1 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Analyst IMS Investment Management Services held 5,145 shares of AbbVie worth $1.12M as of Q1 2026.
Analyst IMS Investment Management Services bought 364 AbbVie shares in Q1 2026, an estimated $80.7K.
AbbVie made up 0.03% of Analyst IMS Investment Management Services's portfolio in Q1 2026, its #81 holding.
Analyst IMS Investment Management Services first reported a position in AbbVie in Q2 2024 and has held it in 8 quarters since.
Analyst IMS Investment Management Services's AbbVie position peaked at $1.17M in Q1 2025.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Analyst IMS Investment Management Services's 13F filing for Q1 2026, filed 23 Apr 2026.